Willems Jeresa I A, van Twist Daan J L, Peeters Robin P, Mostard Guy J M, van Wijngaarden Roderick F A Tummers-de Lind
Department of Internal Medicine, Zuyd Thyroid Center, Zuyderland Medical Center, 6162 BG Sittard-Geleen, The Netherlands.
Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.
J Endocr Soc. 2023 Dec 13;8(1):bvad157. doi: 10.1210/jendso/bvad157. eCollection 2023 Dec 1.
Emotional stress is a precipitating factor for Graves disease (GD). However, the influence of stress relief on the course of GD is unknown. Here, we present a series of patients diagnosed with stress-induced GD in whom stress relief alone led to remission of GD.
We report on 11 patients in whom hyperthyroid symptoms started just after severe emotional stress. All patients had suppressed thyroid-stimulating hormone (TSH) levels and elevated free thyroxine (FT4; 22.2-49.5 pmol/L) and TSH-receptor antibody (TRAb; 0.57-40 U/L) levels and were subsequently diagnosed with stress-induced GD. However, all patients declined antithyroid drug treatment. Surprisingly, clinical and biochemical remission was observed in 9 out of 11 patients after 1 to 3 and 2 to 7 months of self-reported stress relief, respectively. Five patients showed long-lasting remission (median follow-up 2.3 years). In 4 patients, remission was initially achieved, but GD relapsed 1 to 4 years afterwards. In 2 patients, treatment with antithyroid drugs was initiated because of rapidly increasing FT4 levels. Baseline FT4 and TRAb levels tended to be higher in patients who did not achieve remission. Furthermore, patients without long-lasting remission were more frequently known to have prior thyroid disease.
We report on a series of patients with stress-induced GD in whom stress relief alone led to remission of GD (thus without antithyroid drugs). This may indicate that clinicians could consider stopping antithyroid drug treatment or at least shortening the treatment period after stress relief in patients with stress-induced GD.
情绪应激是格雷夫斯病(GD)的一个诱发因素。然而,缓解应激对GD病程的影响尚不清楚。在此,我们报告了一系列被诊断为应激性GD的患者,其中仅通过缓解应激就实现了GD的缓解。
我们报告了11例患者,他们的甲状腺功能亢进症状在严重情绪应激后立即出现。所有患者的促甲状腺激素(TSH)水平均受到抑制,游离甲状腺素(FT4;22.2 - 49.5 pmol/L)和促甲状腺激素受体抗体(TRAb;0.57 - 40 U/L)水平升高,随后被诊断为应激性GD。然而,所有患者均拒绝抗甲状腺药物治疗。令人惊讶的是,分别在11例患者中有9例在自我报告的应激缓解1至3个月和2至7个月后观察到临床和生化缓解。5例患者实现了长期缓解(中位随访2.3年)。4例患者最初实现了缓解,但1至4年后GD复发。2例患者因FT4水平迅速升高而开始使用抗甲状腺药物治疗。未实现缓解的患者基线FT4和TRAb水平往往更高。此外,没有长期缓解的患者更常患有既往甲状腺疾病。
我们报告了一系列应激性GD患者,其中仅通过缓解应激就实现了GD的缓解(因此无需抗甲状腺药物)。这可能表明临床医生在应激性GD患者缓解应激后可以考虑停止抗甲状腺药物治疗或至少缩短治疗期。